Cerenome, Inc. (CNSY)
0.6427
-0.03
(-4.06%)
USD |
NASDAQ |
Nov 06, 16:00
0.6601
+0.02
(+2.71%)
After-Hours: 20:00
Cerenome Cash from Investing (Quarterly) : 5.366M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.366M |
| March 31, 2026 | -8.533M |
| December 31, 2025 | -1.077M |
| September 30, 2025 | 1.297M |
| June 30, 2025 | -4.632M |
| March 31, 2025 | 3.558M |
| December 31, 2024 | 0.064M |
| September 30, 2024 | -0.009M |
| June 30, 2024 | -3.802M |
| March 31, 2024 | -0.364M |
| December 31, 2023 | -0.042M |
| September 30, 2023 | -0.01M |
| June 30, 2023 | -0.011M |
| March 31, 2023 | -0.097M |
| December 31, 2022 | -0.011M |
| September 30, 2022 | -0.033M |
| June 30, 2022 | -0.138M |
| March 31, 2022 | -0.577M |
| December 31, 2021 | 0.002M |
| September 30, 2021 | -0.004M |
| June 30, 2021 | 0.004M |
| March 31, 2021 | -0.084M |
| December 31, 2020 | -0.056M |
| September 30, 2020 | -0.014M |
| June 30, 2020 | -0.412M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.011M |
| December 31, 2019 | 2.789M |
| September 30, 2019 | -0.002M |
| June 30, 2019 | 2.789M |
| March 31, 2019 | -0.006M |
| December 31, 2018 | -0.005M |
| September 30, 2018 | -0.05M |
| June 30, 2018 | -0.025M |
| March 31, 2018 | -0.053M |
| December 31, 2017 | 0.079M |
| September 30, 2017 | -0.166M |
| June 30, 2017 | -0.133M |
| March 31, 2017 | -1.163M |
| December 31, 2016 | 0.174M |
| September 30, 2016 | -0.005M |
| June 30, 2016 | -0.036M |
| March 31, 2016 | -0.069M |
| December 31, 2015 | -0.056M |
| September 30, 2015 | -0.047M |
| June 30, 2015 | -0.323M |
| March 31, 2015 | -0.187M |
| December 31, 2014 | 0.104M |
| September 30, 2014 | -0.325M |
| June 30, 2014 | -0.48M |
| March 31, 2014 | -0.642M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | -311.74M |
| Ernexa Therapeutics, Inc. | -0.003M |
| ACADIA Pharmaceuticals, Inc. | -- |
| Anika Therapeutics, Inc. | -1.28M |
| Savara, Inc. | 32.60M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.132M |
| Cash from Financing (Quarterly) | 1.11M |
| Free Cash Flow | -23.55M |
| Free Cash Flow Per Share (Quarterly) | -1.106 |
| Free Cash Flow to Equity (Quarterly) | -6.95M |
| Free Cash Flow to Firm (Quarterly) | -7.626M |
| Free Cash Flow Yield | -626.6% |